RAPT Capex To Depreciation from 2010 to 2025
| RAPT Stock | USD 26.35 0.44 1.64% |
Capex To Depreciation | First Reported 2010-12-31 | Previous Quarter 0.10141313 | Current Value 0.0963 | Quarterly Volatility 0.59626666 |
Check RAPT Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RAPT Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 1.3 M or Selling General Administrative of 16.7 M, as well as many indicators such as Price To Sales Ratio of 1.7 K, Dividend Yield of 0.0 or PTB Ratio of 2.58. RAPT financial statements analysis is a perfect complement when working with RAPT Therapeutics Valuation or Volatility modules.
RAPT | Capex To Depreciation | Build AI portfolio with RAPT Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.